|
|
Article: Presentation by Windber CSO Highlights Application of InforSense KDE to Translational Medicine.
- Article from:
- Business Wire
- Article date:
- May 10, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LONDON -- InforSense Ltd, the leader in integrative analytics platforms, invites life science researchers and media to attend a presentation entitled "Redefining Translational Medicine for Drug Discovery" at the Drug Discovery & Technology Leaders Summit to be held in Montreux, Switzerland. This presentation by Prof. Michael Liebman, Chief Scientific Officer of the Windber Research Institute (WRI), will describe the ground-breaking workflow-based informatics platform for translational medicine being developed in collaboration with InforSense at WRI.
Traditionally translational medicine has meant the translation of research at the bench to the bedside, i.e. into ...